RADIOSENSITIZING GLIOBLASTOMA IN A RAT MODEL - Ataelmannan, Khalid
32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
16 °P sammeln
  • Broschiertes Buch

Glioblastoma multiforme (GBM) is the most aggressive form of primary brain tumor. Numerous studies have tried to explore various avenues to make this tumor sensitive to radiation therapy and improve the prognosis for patients with this tumor. However, the prognosis for patients with this tumor remains poor with median survival time less than one year.
By using current concepts and techniques of local drug delivery to the brain to sensitize the tumor to radiation therapy, we were able to greatly improve the median survival time in an animal model.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Glioblastoma multiforme (GBM) is the most aggressive
form of primary brain tumor. Numerous studies have
tried to
explore various avenues to make this tumor sensitive
to radiation
therapy and improve the prognosis for patients with
this tumor.
However, the prognosis for patients with this tumor
remains poor
with median survival time less than one year.

By using current concepts and techniques of local
drug delivery to the brain to sensitize the tumor to
radiation
therapy, we were able to greatly improve the median
survival time in
an animal model.
Autorenporträt
Dr Atealmannan (MBBS, MSc, AFWACS, FRCS) is a member of a
multidisciplinary team
at the University of Saskatchewan, Canada working on brain tumor
research. This
work was done as part of his thesis research for a master degree
in Surgery.

Dr Ataelmannan is a General Surgeon and is married with two children